Electronic address: a.vanharen-maassenvandenbrink@erasmusmc.nl. 2 Department of Neurology, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The ...
Antoinette MaassenVanDenBrink
Researcher
Education: Erasmus University Rotterdam (1995–1999)
People also ask
What is the success rate of topiramate for migraines?
What is the best CGRP inhibitor?
What is the strongest preventive medicine for migraines?
How can I lower my CGRP naturally?
May 19, 2023 · Authors. Christian Lampl , Antoinette MaassenVanDenBrink , Christina I Deligianni , Raquel Gil-Gouveia , Tanvir Jassal ...
May 19, 2023 · Intellectual Antoinette MaassenVanDenBrink is vice-president of the European Headache Federation and associate editor for The Journal of ...
Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European ...
Principal Investigator: Antoinette Maassenvandenbrink | ResearchGate, the professional network for scientists.
A MaassenVanDenBrink et al. Wiping Out CGRP: potential cardiovascular risks. Trends Pharmacol Sci. (2016).
A Maassen van den Brink has received grants and/or fees from Amgen/Novartis, Lilly, and Teva. The authors have no other relevant affiliations or financial ...
Oct 17, 2023 · MaassenVanDenBrink reports consultancy or industry grant support from Novartis, Lilly and Teva, and independent support from the Dutch Research ...
Jun 1, 2011 · ... MaassenVanDenBrink, Division of Vascular Medicine and Pharmacology ... MaassenVanDenBrink); Department of Neurology, Leiden University ...
Pharmacological treatment of migraine: CGRP and 5-HT beyond the triptans. T de Vries, CM Villalón, A MaassenVanDenBrink. Pharmacology & Therapeutics 211, 107528 ...